chr1-1419141-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001145210.3(ANKRD65):c.1159G>T(p.Gly387Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,534,904 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G387A) has been classified as Uncertain significance.
Frequency
Consequence
NM_001145210.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANKRD65 | NM_001145210.3 | c.1159G>T | p.Gly387Trp | missense_variant | 4/4 | ENST00000537107.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANKRD65 | ENST00000537107.6 | c.1159G>T | p.Gly387Trp | missense_variant | 4/4 | 5 | NM_001145210.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152274Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000139 AC: 2AN: 144214Hom.: 0 AF XY: 0.0000130 AC XY: 1AN XY: 77184
GnomAD4 exome AF: 0.0000239 AC: 33AN: 1382512Hom.: 0 Cov.: 31 AF XY: 0.0000265 AC XY: 18AN XY: 678806
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152392Hom.: 0 Cov.: 34 AF XY: 0.0000537 AC XY: 4AN XY: 74524
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 22, 2024 | The c.1159G>T (p.G387W) alteration is located in exon 4 (coding exon 3) of the ANKRD65 gene. This alteration results from a G to T substitution at nucleotide position 1159, causing the glycine (G) at amino acid position 387 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at